1. EXPOSURE-RISK RELATIONSHIP FOR BENZENE Position Paper of the German AGS Gisela H. Degen Leibniz Research Centre for Working Environment and Human Factors at the TU Dortmund…

Slide 1Ahmed Group Lecture 26 Radiation-induced carcinogenesis Lecture 26 Slide 2 Ahmed Group Lecture 26 Initiation, promotion, progression Dose response for radiation-induced…

Slide 1 Hanahan & Weinberg: The hallmarks of cancer. Cell 100:57-70, 2000 Slide 2 ONCOGENE ACTIVATION Slide 3 Slide 4 TUMOR SUPPRESSOR INACTIVATION p53 Slide 5 TUMOR…

Tumor Immunology Ziad Elnasser, MD, Ph.D Tumor Immunology Two main strands of tumour immunology.  Genetics.  Pathogens.  Tumors of lymphoid cells.  Tumor immunotherapy.…

1. Targeting p53 for Novel Anticancer Therapy Presented by- Diksha Kumari Anurag Chanda Anindita Biswas B.pharm ,4thyr,7th Semester Guru Nanak Institute of Pharmaceutical…

Slide 1 Nonclinical Studies Subcommittee Advisory Committee for Pharmaceutical Science Introduction & FDA Objectives Gaithersburg Hilton December 14, 1999 T:\NCSS\121499.PPT…

Slide 1 Mechanisms of Transformation by Retrovirues Virology 324A Dept. of Microbiology and Immunology McGill University Dr. John Hiscott 340-8222 ext. 5265 [email protected]…

Slide 1 Neoplasia II Slide 2 Molecular basis of cancer Nonlethal genetic damage Tumors are monoclonal Four classes of normal regulatory genes are principal targets of genetic…

Reactive oxygen species; a step to REACTIVE OXYGEN SPECIES MANAGEMENT; A STEP TO DEVELOP ANTI-CANCER THERAPY Ms. Bushra Allah Rakha Lecturer Department of Wildlife Management…

Nonclinical Studies Subcommittee Advisory Committee for Pharmaceutical Science Introduction & FDA Objectives Gaithersburg Hilton December 14, 1999 T:\NCSS\121499.PPT…